Dexcom (DXCM) Other Non-Current Liabilities (2010 - 2026)

Dexcom (DXCM) has 17 years of Other Non-Current Liabilities data on file, last reported at $141.8 million in Q1 2026.

• Quarterly Other Non-Current Liabilities fell 5.66% year-over-year to $141.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $141.8 million (down 5.66% YoY) and the FY2025 annual result came in at $137.1 million, down 7.3% from the prior year.
• Other Non-Current Liabilities improved to $141.8 million in Q1 2026 per DXCM's latest filing, from $137.1 million in the prior quarter.
• Across five years, Other Non-Current Liabilities topped out at $151.6 million in Q2 2025 and bottomed at $97.1 million in Q1 2022.
• The 5-year median for Other Non-Current Liabilities is $129.7 million (2023), against an average of $131.4 million.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities jumped 42.56%; it then dropped 7.3% in 2025.
• Tracing DXCM's Other Non-Current Liabilities over 5 years: stood at $128.3 million in 2022, then declined by 2.1% to $125.6 million in 2023, then increased by 17.75% to $147.9 million in 2024, then fell by 7.3% to $137.1 million in 2025, then gained by 3.43% to $141.8 million in 2026.
• Per Business Quant, the three latest DXCM Other Non-Current Liabilities figures stand at $141.8 million (Q1 2026), $137.1 million (Q4 2025), and $147.4 million (Q3 2025).

Peer Comparison